NAMS CIK: 1936258

NewAmsterdam Pharma Co N.V.

  • Netherlands
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.5
FY22:
10.7
FY23:
−141
FY24:
−159
FY25:
−148
Change from FY21 to FY25
millions USD
FY21:
−0.02
FY22:
−0.22
FY23:
−0.02
FY24:
−62.8
FY25:
−175
Change from FY21 to FY25
millions USD
FY21:
84.7
FY22:
392
FY23:
8.91
FY24:
660
FY25:
29.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.5
FY22:
10.4
FY23:
−141
FY24:
−159
FY25:
−148

All amounts in millions USD Data source:SEC EDGAR